Dr. Joseph Kozikowski will present on corporate governance to executive leadership at Johnson & Johnson Global Headquarters.
NATICK, MA – February 1, 2009 – Clinivation, Inc. announced today that clinivation Founder and CEO Joseph Kozikowski, M.D. will present to executive leadership at Johnson & Johnson Global Headquarters.
As an authority on the development and commercialization of advanced medical technology, and having led thousands of new submissions, renewals, refilings, novated submissions for major multinationals worldwide, Dr. Kozikowski will share his perspectives in a presentation entitled “Effective Governance of Global Market Clearance Operations.”
The presentation will address innovative approaches and important industry best practices, and will include discussions on value creation, effective governance, and enabling execution with information technology.
More specifically, Dr. Kozikowski will present how contemporary corporate governance has direct purview over global market clearance operations. Indeed, achieving sustainable compliance with Sections 302, 404, and 406 of the Sarbanes-Oxley Act requires executives to establish and test controls for management visibility, provide governance of export compliance, and effect management sign-off on a code of ethics that mandates compliance with all “applicable governmental rules and regulations.”
And because companies must report related deficiencies, companies are now disclosing export control deficiencies in their annual 10K securities filings. New SEC “disclosure reform” and “shareholder rights” legislation are creating additional requirements for managing market clearance operational compliance and risk.
In this presentation, he will also examine how effective governance is enabled by gaining visibility on the entire process and status of global market clearance operations, delivering comprehensive regulatory intelligence into day-to-day activities, and integrating of automated, clearance-driven business controls into selling, production, and shipping processes. He will also discuss how achieving effective governance and sustainable compliance creates enterprise value.
The audience will include the Johnson & Johnson Global Compliance Team, legal, regulatory affairs, and other executive leadership. The presentation will be held in conjunction with the Office of General Counsel on February 7, 2009 at the Johnson & Johnson Global Headquarters, New Brunswick, NJ.
Following the presentation, Dr. Kozikowski will be available for discussions and meetings to discuss the topics in greater depth.
Quotes & Commentary:
“It is an honor to have been invited to present, and I thank the Office of General Counsel and executive leadership for their efforts in arranging this opportunity for learning,” said clinivation Founder and CEO Joseph Kozikowski, M.D.
About Johnson & Johnson:
Caring for the world, one person at a time…inspires and unites the people of Johnson & Johnson. We embrace research and science — bringing innovative ideas, products and services to advance the health and well-being of people. Our 119,000 employees at more than 250 Johnson & Johnson companies work with partners in health care to touch the lives of over a billion people every day, throughout the world.
